PDCD1 and neoplasm: Overall, our results provide evidence that significant variations in lipid metabolism and specific lipid species are observed in tissues in response to anti-PD-1 treatment, exemplified by an increased PUFA lipid signal in tumor-infiltrating T cells, and thus may be valuable immunometabolic pathways correlating with anti-PD-1 efficacy.